The KIR3DL2 gene gives certain immune cells a surface receptor that helps them read signals from other cells and keep immune responses in balance. This gene plays an important role in helping natural killer cells and some T cells decide when to stay quiet and when to respond. If it does not work properly, that balance can shift and may affect how these cells behave. In medicine, KIR3DL2 is best known as a marker linked to some rare T cell blood and skin cancers.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or manage processes in the body. Some genes provide the code for proteins, which are the parts of cells that do much of the work. Other genes mostly help regulate when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, or medicines. For a deeper look at this topic, you can read more in the LearnHub.
Overview
KIR3DL2Gene function
What if the gene works
The KIR3DL2 gene helps natural killer cells and some T cells recognize signals on other cells. This supports balanced immune responses and helps prevent these cells from attacking healthy tissue.
Risk
What if the gene does not work
Changes in the KIR3DL2 gene can range from milder to more severe variants. These may reduce or alter a surface receptor on natural killer cells, changing how these cells sense body signals and dampen or fine tune immune responses.
Treatment
What does that mean for your treatment
No KIR3DL2-specific treatment or drug choice approach is currently established for people with a pathogenic or loss-of-function variant in the KIR3DL2 gene. Separately, KIR3DL2 on cancer cells is being studied as a biomarker and drug target in some rare T-cell lymphomas, including with the antibody lacutamab.
Gene function
What if the gene works
Immune cells need calm control as they patrol the body. In your immune system, the KIR3DL2 gene helps natural killer cells recognize healthy cells and avoid unnecessary attack. It also supports steady communication between cell surface markers and the immune cells reading those signals.
The protein made from the KIR3DL2 gene binds certain HLA class I markers, protein tags on cell surfaces that help show a cell is part of the body. This helps natural killer cells recognize healthy cells during routine immune patrol.
When this receptor meets the right surface marker, it sends a slowing signal into the immune cell. That brake helps prevent unnecessary attack on normal tissues while immune cells keep watching for real threats.
The KIR3DL2 gene works with other receptors on natural killer cells and some T cells to weigh stop and go messages. This balance supports a measured response during everyday contact with other cells.
What is a variant?
A genetic variant is a slight difference in the DNA sequence of a gene. These differences are common and help shape normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. At times, though, a variant can change how a gene functions more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the KIR3DL2 gene can change how much receptor reaches the cell surface, how stably it folds, or how well it interacts with its binding partners. How variants in the KIR3DL2 gene affect protein function often depends on where the DNA change sits: milder variants may slightly alter signaling, while more severe variants can greatly reduce receptor stability or block normal cell-surface expression. Some changes may also weaken the receptor’s ability to bind specific HLA class I molecules.
How variants are linked to conditions
At this time, KIR3DL2 gene variants linked to health conditions have not been connected to one specific, broadly confirmed inherited condition. Research has explored possible associations with some immune conditions, but the findings are not consistent enough to define a clear diagnosis from the KIR3DL2 gene alone, so anyone with a reported variant should rely on guidance from their doctor or genetic counselor.
A variant is not necessarily a diagnosis
Gene variants are a normal feature of human biology and are widely found in the general population. Most have no direct impact on health and simply reflect natural human variation. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when more than one gene and environmental influences are involved. In some situations, however, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the KIR3DL2 gene itself. Anyone concerned about personal or family risk can talk with a doctor or genetic counselor for advice based on their own medical history.
Inheritance of KIR3DL2 variants
There is not yet a broadly confirmed Mendelian pattern for the inheritance of the KIR3DL2 gene variants tied to a specific human condition, and this picture may become clearer as research develops. In practice, inheritance of the KIR3DL2 gene variants reflects the fact that KIR3DL2 sits on chromosome 19, which is an autosome. That means you inherit one copy in your chromosome set from each parent, regardless of sex.
What does my KIR3DL2 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific inherited condition for KIR3DL2, though this understanding can change as research develops. If you have a specific KIR3DL2 result and want to know what it could mean for relatives, a doctor or genetic counselor can help explain it in the context of your family history.
Genetic information
Genetic testing
How you find out about variants
Testing for variants in the KIR3DL2 gene usually starts with a blood or saliva sample. In KIR3DL2 gene genetic testing, a lab reads the DNA, often using targeted sequencing or a broader immune gene panel, and compares it with a reference sequence to identify variants.
When should I consider getting a genetic test?
There is not yet a broadly established, KIR3DL2-specific reason for genetic testing in routine care. Decisions about testing are usually based on your personal health and family history, best discussed with a doctor or genetic counselor.
A genetic result is only one part of your health story
Genetic results can be informative, but what they can tell you varies with the condition and the kind of variant involved. Over time, the way the body works is also shaped by factors like lifestyle, environment, age, and medical history. With some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood alongside the rest of a person’s care. In other situations, a genetic result may give a clear answer. In areas such as response to medications, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small inherited differences can change how the body breaks down a drug, moves it through the body, or responds to it where it works. This is common and helps explain why the same treatment works well for one person, has less effect in another, or causes more side effects in someone else. Medication response is also shaped by other factors, including age, overall health, and other medicines.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that looks at how genetic differences affect the way people respond to medications. It examines connections between genes and drugs to better explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strong a drug’s effects are or how the body handles it. This information can help support treatment decisions that are more informed and more personalized. For a deeper look at this subject, you can learn more in the LearnHub.
Drugs influenced by the KIR3DL2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choice or predicting side effects, so general medication or health concerns are best discussed with your doctor. Seek medical advice if a treatment is not working as expected, causes troublesome side effects, or you are worried about how a medicine may affect you.
History
In the 1990s, researchers began sorting natural killer cell receptors into the family now called KIR, and KIR3DL2 emerged as one of the better defined members. Early papers also referred to it by names such as CD158k and p140, reflecting a period when immune markers were often identified before naming systems were standardized. Scientific classifications changed as researchers learned more about the gene. Interest in KIR3DL2 grew further when it became linked to studies of cutaneous T cell lymphoma, especially Sézary syndrome, where its protein marker helped improve disease recognition. That work gave KIR3DL2 a place not only in basic immunology but also in clinical pathology. Over time, descriptions became more precise as gene mapping and sequencing clarified how KIR3DL2 fits within the larger KIR region on chromosome 19.